Clinical trial

Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly…

NCT00028795 · Children's Oncology Group, Other · Completed

Key facts

NCT number NCT00028795
Title Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
Official title A Phase II Study of Temozolomide in the Treatment of Children With High Grade Glioma
Lead sponsor Children's Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Brain and Central Nervous System Tumors
Intervention type Drug, Procedure, Radiation
Interventions temozolomide, adjuvant therapy, radiation therapy
Enrollment 170
Start date Dec 1, 2002
Primary completion Sep 1, 2007
Completion Mar 1, 2012
First posted Jan 27, 2003
Last update posted Feb 21, 2014
Countries Australia, Canada, Netherlands, New Zealand, Puerto Rico, Switzerland, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies